Pages that link to "Q33378814"

The following pages link to Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children (Q33378814):

Displaying 50 items.

• Vaccines for measles, mumps and rubella in children (Q24203667) (← links)
• Do childhood vaccines cause thrombocytopenia? (Q24652460) (← links)
• The Xs and Y of immune responses to viral vaccines (Q24706476) (← links)
• Frequently asked questions on seven rare adverse events following immunization (Q30234430) (← links)
• The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. (Q30365533) (← links)
• Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies. (Q30795124) (← links)
• The ITP syndrome: pathogenic and clinical diversity (Q33384235) (← links)
• Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy (Q33387447) (← links)
• Thrombocytopenia after vaccination: Case reports to the US Vaccine Adverse Event Reporting System, 1990–2008 (Q33393117) (← links)
• Thrombocytopenic Purpura Following Vaccination in Early Childhood: Experience of a Medical Center in the Past 2 Decades (Q33393216) (← links)
• Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura (Q33395175) (← links)
• A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark (Q33395909) (← links)
• Idiopathic immune-mediated thrombocytopenia and recent vaccination in dogs (Q33398628) (← links)
• A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design (Q33405209) (← links)
• Vaccine administration and the development of immune thrombocytopenic purpura in children (Q33405328) (← links)
• Clinical practice: immune thrombocytopenia in paediatrics (Q33412475) (← links)
• Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines (Q33414858) (← links)
• Adversomics: the emerging field of vaccine adverse event immunogenetics (Q33744268) (← links)
• A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research (Q34301732) (← links)
• Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013 (Q35661817) (← links)
• Sex-based differences in immune function and responses to vaccination (Q35661949) (← links)
• Pharmacovigilance in children: detecting adverse drug reactions in routine electronic healthcare records. A systematic review. (Q36125536) (← links)
• Physicians' confidence in vaccine safety studies (Q36175636) (← links)
• Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 (Q36478305) (← links)
• Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007. (Q37321101) (← links)
• Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink's Rapid Cycle Analysis Capabilities (Q37327861) (← links)
• Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination (Q37805175) (← links)
• Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice (Q37919183) (← links)
• Active surveillance for adverse events following immunization (Q38172268) (← links)
• Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil (Q38422610) (← links)
• Immunization Coverage Among Juvenile Justice Detainees. (Q38530548) (← links)
• Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative (Q38638978) (← links)
• Adverse events following immunization: real causality and myths (Q38778111) (← links)
• A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program (Q39029570) (← links)
• Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination (Q39350135) (← links)
• White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink (Q40037202) (← links)
• Comparison of epidemiologic methods for active surveillance of vaccine safety (Q40094601) (← links)
• MMR and MMRV vaccines (Q40102310) (← links)
• Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: a regulatory perspective (Q41156699) (← links)
• Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon? (Q42361533) (← links)
• Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology. (Q43848105) (← links)
• Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity (Q44475855) (← links)
• Confounder adjustment in vaccine safety studies: comparing three offset terms for case-centered approach (Q46652822) (← links)
• Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network. (Q48605471) (← links)
• Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b (Q56795571) (← links)
• Vaccines for measles, mumps and rubella in children (Q57272255) (← links)
• Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany (Q59355601) (← links)
• Risk of immune hemolytic anemia in children following immunization (Q59363149) (← links)
• Demonstration of background rates of three conditions of interest for vaccine safety surveillance (Q61817411) (← links)
• The vaccine adverse event reporting system and vaccine safety research in the genomics era (Q83005846) (← links)